Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's EV-to-FCF or its related term are showing as below:
SHSE:600529'
s EV-to-FCF Range Over the Past 10 Years
Min: -5045.08 Med: 24.86 Max: 2737.35
Current: 27
During the past 13 years, the highest EV-to-FCF of Shandong Pharmaceutical Glass Co was 2737.35. The lowest was -5045.08. And the median was 24.86.
SHSE:600529's EV-to-FCF is ranked worse than 67.49% of 243
companies
in the Packaging & Containers industry
Industry Median: 16.4
vs SHSE:600529: 27.00
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Pharmaceutical Glass Co (SHSE:600529) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Pharmaceutical Glass Co's PE Ratio (TTM) for today is calculated as:
Shandong Pharmaceutical Glass Co's share price for today is ¥18.91.
Shandong Pharmaceutical Glass Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shandong Pharmaceutical Glass Co EV-to-FCF Related Terms
Shandong Pharmaceutical Glass Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co EV-to-FCF vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's EV-to-FCF falls into.
Shandong Pharmaceutical Glass Co's current Enterprise Value is ¥9,936 Mil.
Shandong Pharmaceutical Glass Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥365 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a EV-to-FCF of 27.23 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 10% above median its historical median of 24.86. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #164 out of 243 companies in the Packaging & Containers industry, placing it in the top 67.5%.
Is Shandong Pharmaceutical Glass Co's EV-to-FCF too high?
Shandong Pharmaceutical Glass Co's current EV-to-FCF of 27.23 is 10% above median its 10-year median of 24.86. The Packaging & Containers industry median EV-to-FCF is 16.40. Shandong Pharmaceutical Glass Co's value of 27.23 is 66% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #164 out of 243 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's EV-to-FCF compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #164 out of 243 companies for EV-to-FCF. This places Shandong Pharmaceutical Glass Co in the lower half of its industry. The industry median EV-to-FCF is 16.40. Shandong Pharmaceutical Glass Co's value of 27.23 is 66% above this benchmark. While the company's 10-year median is 24.86 vs. the industry median of 16.40, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Packaging & Containers company?
The median EV-to-FCF among Packaging & Containers companies is 16.40, based on 243 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current EV-to-FCF of 27.23 is 66% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median EV-to-FCF is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current EV-to-FCF is 27.23, which is 10% above median its own 10-year median of 24.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.31, compared to a current price of ¥18.91 — trading 22.2% below its estimated fair value. The current EV-to-FCF is 27.23, which is 10% above median its 10-year median of 24.86 and 66% above the Packaging & Containers industry median of 16.40. Shandong Pharmaceutical Glass Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current EV-to-FCF is 27.23 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥18.91 is trading 22.2% below its estimated GF Value™ of ¥24.31.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
EV-to-FCF: 27.23 (10% above median its 10-year median of 24.86)
GF Value™: ¥24.31 vs. price of ¥18.91 (22.2% below fair value)
Industry Position: 66% above the Packaging & Containers median (#164 of 243)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
90GF Score
Get the complete analysis for SHSE:600529
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
